Effect of Non-Statin Lipid-Lowering Therapy on Hepatic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review

Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are significant health concerns affecting a large segment of the population and are known to be associated with adverse cardiovascular outcomes. As a result, various lipid-low...

Description complète

Détails bibliographiques

Auteurs principaux:	Walter Masson, Leandro Barbagelata, Juan Patricio Nogueira
Format:	Artigo
Langue:	Inglês
Publié:	The Korean Society of Lipid and Atherosclerosis 2025-09-01
Collection:	Journal of Lipid and Atherosclerosis
Sujets:	non-alcoholic fatty liver disease ezetimibe pcsk9 inhibitors eicosapentaenoic acid bempedoic acid
Accès en ligne:	https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2025.14.3.273&code=9992JLA&vmode=FULL
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!